Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Daming Zhou, Wanwisa Dejnirattisai, Piyada Supasa, +41

Cell

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, +59

Cell

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

Aekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, +27

Cell

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Chang Liu, Helen M. Ginn, Wanwisa Dejnirattisai, +56

Cell

Viral DiagnosticsVaccine SeraImmunologyViral PathogenesisUnited Kingdom +16

Antibody evasion by the P.1 strain of SARS-CoV-2

Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, +47

Cell

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Piyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, +50

Cell

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

Rungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, +32

Cell

Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa

Aekkachai Tuekprakhon, Siripakorn Sangkitporn, Adisak Trinavarat, +12

Stem Cell Research & Therapy

Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, +68

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants

Chang Liu, Daming Zhou, Rungtiwa Nutalai, +28

Cell Host & Microbe

VaccinationViral EvolutionVaccine TargetHumoral ResponseImmunology +8